Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
05/2004
05/06/2004US20040086256 Continuously variable attenuation of an optical signal using an optical isolator
05/06/2004EP1414989A1 Organometallic probe
05/06/2004EP0889739A4 Measurement of gastric emptying
05/06/2004CA2503245A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
05/06/2004CA2501684A1 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
05/06/2004CA2500542A1 Method for the production of hyperpolarized 129xe
05/05/2004CN1494553A Modified antibodies and method of use
05/05/2004CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders
05/04/2004US6730699 Water soluble paclitaxel derivatives
05/04/2004US6730477 Includes measuring levels of a breast specific gene (bsg) in cells, tissues or bodily fluids in a patient and comparing to a normal human control
05/04/2004US6730286 Medical diagnosis; scanning tissue, organs; albumin label with radioactive materials
04/2004
04/29/2004WO2004035744A2 Methods for purifying radiolabelled compounds
04/29/2004WO2004035536A2 Azo compounds for type i phototherapy
04/29/2004WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/29/2004WO2004035093A2 Polymeric materials for site specific delivery to the body
04/29/2004WO2004035022A2 Prepolymeric materials for site specific delivery to the body
04/29/2004WO2004034876A2 Magnetically guided particles for radiative therapies
04/29/2004WO2004019999A3 Agent delivery particle
04/29/2004WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor
04/29/2004WO2003103723A3 Neutrophil imaging methods in cyctic fibrosis
04/29/2004WO2003099810A3 Radiopharmaceuticals for imaging infection and inflammation
04/29/2004WO2003086172A3 Method for tagging colonic residue
04/29/2004WO2003020949A3 Targeted nucleic acid constructs and uses related thereto
04/29/2004US20040082499 Perturbed membrane-binding compounds
04/29/2004US20040081994 Measuring efficiency of exercise; measuring isotropic patterns; sensitivity to cardiovascular disorders
04/29/2004US20040081689 Activating a fluid ejector actuator to eject a bioactive fluid onto at least a portion of an interior surface of said enclosing medium
04/29/2004US20040081660 Polypeptide and protein derivatives and process for their preparation
04/29/2004US20040081617 Ferrites labeled with radioactive material; medical trancers; imaging therapy
04/29/2004US20040081616 Medical diagnosis; cardiovascular disorders
04/29/2004CA2502211A1 Azo compounds for type i phototherapy
04/29/2004CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/28/2004EP1414004A1 Lesion phantoms with no inner cold encapsulation
04/28/2004EP1413434A1 Pharmaceutical dosage form and method of making
04/28/2004EP1412388A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
04/28/2004EP1411993A2 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
04/28/2004EP1411987A2 Targeted polymeric delivery systems
04/28/2004EP1411925A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity
04/28/2004EP1012190A4 Eosinophil eotaxin receptor
04/28/2004EP0856054B1 Monoclonal antibody br110 and uses thereof
04/28/2004EP0785928B1 NOVEL N3 S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS
04/28/2004EP0777498B1 Conjugates made of metal complexes and oligonucleotides
04/28/2004CN1147584C Modulators of tissue regeneration
04/27/2004US6727274 Use in treating conditions in which 5-ht6 receptors are involved such as anxiety, depression, schizophrenia, alzheimer's disease, stress-related disease, nervous system disorders; use in performing positron emission tomography
04/27/2004US6726895 Tumor radiotherapy
04/24/2004CA2446094A1 Pharmaceutical dosage form and method of making
04/22/2004WO2004034411A1 Stabilized superparamagnetic particles
04/22/2004WO2004033667A2 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
04/22/2004WO2004032975A2 Biphenyls and fluorenes as imaging agents in alzheimer's disease
04/22/2004WO2004032962A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
04/22/2004WO2004032936A1 Improved imaging agents comprising barbituric acid derivatives
04/22/2004WO2004032857A2 Antibody therapy
04/22/2004WO2004032708A2 Vasoregulating compounds and methods of their use
04/22/2004WO2004022105A3 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
04/22/2004WO2004007557A3 Tf antagonist
04/22/2004WO2004002984A3 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules
04/22/2004WO2002092782A3 Diagnosis and treatment of malignant neoplasms
04/22/2004US20040077944 Combined impedance imaging and mammography
04/22/2004US20040076629 Polypeptide with 46 kDalton HMFG differentiation antigen binding specificity and clotting factors V and VIII light-chain homologies, fusion protein, polynucleotide and polyribonucleotide encoding the polypeptide, anti-polypeptide antibodies, kits and methods of use thereof
04/22/2004US20040076582 Comprises spherical/micronized polyvinyl alcohol particle containing radioactive species; monoclonal antibodies
04/22/2004US20040076581 For diagnosis/treatment of breast cancer, ovarian cancer, and glioblastomas; kits
04/22/2004US20040076580 For diagnosis/treatment of thrombosis, embolism, atherosclerosis, inflammation or cancer; imaging
04/22/2004US20040076579 For use in radiology; for attachment to catheters
04/22/2004US20040076258 Lesion phantoms with no inner cold encapsulation
04/22/2004CA2501616A1 Antibody therapy
04/22/2004CA2501527A1 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
04/22/2004CA2501136A1 Improved imaging agents comprising barbituric acid derivatives
04/21/2004EP1410035A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
04/21/2004EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
04/21/2004EP1409550A1 Extracellular messengers
04/21/2004EP1409549A2 Compositions and methods for the diagnosis and treatment of tumor
04/21/2004EP1409537A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
04/21/2004EP1409026A1 Kit for intraperitoneal administration and extracorpeal removal of a drug
04/21/2004EP1409024A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
04/21/2004EP0693924B1 Methods for (in vivo) delivery of biologics and compositions useful therefor
04/20/2004US6723746 Functional radiographic imaging methods and agents
04/20/2004US6723318 Targeting of biomolecules
04/15/2004WO2003102579A3 Method of screening groups of radioactive molecules and applications thereof
04/15/2004WO2003080554A3 Iodinated triglyceride analogs
04/15/2004WO2003078393A3 Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters
04/15/2004WO2003070752A3 Mhc-peptide complex binding ligands
04/15/2004WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/15/2004WO2003019142A3 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque
04/15/2004US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
04/15/2004US20040072847 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
04/15/2004US20040072755 A fusion proteins, a binding proteins as anticarcinogenic agents for treating cancer, antiinflammatory agents, treating atherosclerosis and ischemia/ reperfusion
04/15/2004US20040072371 Compositions for labeling beta-amyloid plaques and neurofibrillary tangles
04/15/2004US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses
04/15/2004US20040071711 Imaging, diagnosis and treatment of disease
04/15/2004US20040071698 Human anti-epidermal growth factor receptor single-chain antibodies
04/15/2004US20040071692 Minimizes toxicity to normal tissue; high therapeutic index
04/15/2004US20040071690 High avidity polyvalent and polyspecific reagents
04/15/2004US20040071632 Determining plaque location using human monoclonal antibody fragment cloned by phage display that binds specifically to oxidized forms of low density lipoproteins
04/15/2004US20040071631 Use of radiopharmaceuticals and intraoperative radiation probe for delivery of treatment materials
04/14/2004EP1406930A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
04/14/2004EP1406879A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents
04/14/2004EP1406669A2 Conjugates of an antioxidants with metal chelating ligands
04/14/2004EP1406664A2 Targeting chemical compounds to cells
04/14/2004EP1406636A2 System and method for the large scale labeling of compounds with radiohalogens
04/14/2004EP1214312B1 5-aminoalkyl and 5-aminocarbonyl substituted indoles
04/14/2004CN1489478A Medicine preparations for diagnosing infection with helicobacter pyloni